-- Investment Will Support Leading Global Nutritional Products Provider's 
Mission to Improve Health Outcomes in Partnership with Healthcare Practitioners

Gryphon Investors ("Gryphon"), a leading middle-market private equity firm, 
today announced that it has signed a definitive agreement to acquire 
Metagenics, Inc. from Alticor Inc. Metagenics is a leading global 
practitioner-recommended nutritional supplement company. In partnership with 
Metagenics' leadership team, including CEO Brent Eck, Gryphon will continue to 
invest in Metagenics' global mission of providing effective nutritional 
solutions recommended by healthcare professionals to help people live happier, 
healthier lives. Financial terms of the transaction were not disclosed. The 
transaction is expected to close in the fourth quarter of 2021.

Founded in 1983 and based in Aliso Viejo, CA with facilities in North America, 
Europe, and Australia, Metagenics creates clinically proven and transparent 
nutrition programs and products to support good health. Its more than 850 
natural health products span seven functional areas, including digestive 
health, foundational health, cardiometabolic/immune response, neurological 
health, immune health, women's health, and bariatric health. For over 35 years, 
Metagenics has partnered with healthcare practitioners who recommend its 
nutritional products to support their patients' health with measurable results.

Metagenics' management team will continue to be led by CEO Brent Eck. As part 
of the transaction, Gryphon Executive Advisor Steve LaMonte will become 
Executive Chairman of the Metagenics Board. This will be the fourth investment 
on which Gryphon and Mr. LaMonte have partnered. He will be one of several 
Gryphon executive advisors to join the board along with Gryphon Operating 
Partner Mike Ferry, Gryphon Deal Partner Matt Farron, and Gryphon Managing 
Director Ryan Fagan. The transaction marks Gryphon's third investment in 
consumer health products and first investment in the nutritional health 
category.

Gryphon Operating Partner Mike Ferry said, "Metagenics has a unique position as 
a leader among nutrition brands recommended by healthcare practitioners across 
its three core geographic markets. We are excited to invest behind the 
Metagenics mission, including helping their healthcare practitioner partners to 
support the health of their patients around the world."

Ryan Fagan, Managing Director in Gryphon's Consumer Group, said, "We're happy 
to partner with a company that operates at the gold standard of scientific 
credibility, quality, innovation, and sourcing transparency. Both healthcare 
practitioners and their patients are increasingly focused on making proactive 
healthy lifestyle choices, and nutrition is a necessary part of that effort. 
Gryphon has been searching for the right platform to invest behind this 
movement for several years and we will continue to actively search for similar 
opportunities—potential acquisitions for Metagenics as well as incremental 
independent platforms in the health and wellness category."

Mr. Eck commented, "We are delighted to partner with the team at Gryphon as we 
plan for long-term sustainable growth for the Metagenics brand around the 
world. Gryphon brings a truly differentiated set of capabilities as a partner, 
and their investment will allow us to invest for the future, both organically 
and through strategic acquisitions."

Matt Farron, Partner and Head of Gryphon's Consumer Group, added, "Metagenics 
has a passionate organization led by a highly professional senior management 
team. We are thrilled about the potential for our partnership and the long-term 
future of this business."

Jefferies LLC and Solomon Partners are serving as financial advisors to 
Gryphon. Nomura Securities International, Inc. and William Hood & Company are 
serving as co-lead financial advisors to Alticor. Kirkland & Ellis LLP is 
acting as legal advisor to Gryphon, and Bryan Cave Leighton Paisner LLP is 
acting as legal advisor to Alticor. 

About Metagenics
Founded in 1983 and based in Aliso Viejo, CA with facilities in North America, 
Europe, and Australia, Metagenics is a leading global nutritional supplement 
company. Metagenics uses the science of nutritional genomics to create 
nutrition programs and products to support good health. Its more than 850 
natural health products span seven functional areas, including digestive 
health, foundational health, cardiometabolic/immune response, neurological 
health, immune health, women's health, and bariatric health. For more 
information, visit www.metagenics.com.

About Gryphon Investors
Based in San Francisco, Gryphon Investors (www.gryphoninvestors.com) is a 
leading private equity firm focused on profitably growing and competitively 
enhancing middle-market companies in partnership with experienced management. 
The firm has managed over $7.5 billion of equity investments and capital since 
1997. Gryphon targets making equity investments of $50 million to $300 million 
in portfolio companies with enterprise values ranging from approximately $100 
million to $600 million. Gryphon prioritizes investment opportunities where it 
can form strong partnerships with owners and executives to build leading 
companies, utilizing Gryphon's capital, specialized professional resources, and 
operational expertise.

Contact:
Lambert & Co.
Caroline Luz
+1 203-656-2829
cluz@lambert.com

or

Jennifer Hurson
+1 845-507-0571
jhurson@lambert.com


SOURCE: Gryphon Investors